Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Burcon NutraScienceBRCNF 32 Debt-to-EBITDA is -2.20 as of Mar. 2026. GuruFocus rates BRCNF with a GF Score™ of 32/100 and a GF Value™ of $7.65 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 1,554 Consumer Packaged Goods companies, Burcon NutraScience ranks worse than 64350% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Burcon NutraScience's Debt-to-EBITDA or its related term are showing as below:
BRCNF'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -3.31 Med: -0.56 Max: 0.12
Current: -2.53
During the past 13 years, the highest Debt-to-EBITDA Ratio of Burcon NutraScience was 0.12. The lowest was -3.31. And the median was -0.56.
BRCNF's Debt-to-EBITDA is ranked worse than 100% of 1554
companies
in the Consumer Packaged Goods industry
Industry Median: 2.065
vs BRCNF: -2.53
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Burcon NutraScience Debt-to-EBITDA Related Terms
Burcon NutraScience Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Burcon NutraScience's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Burcon NutraScience's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Burcon NutraScience Debt-to-EBITDA vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Burcon NutraScience's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Burcon NutraScience's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Burcon NutraScience (BRCNF) has a Debt-to-EBITDA of -2.20 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Burcon NutraScience. According to the industry distribution chart, Burcon NutraScience ranks #999999 out of 1554 companies in the Consumer Packaged Goods industry.
Is Burcon NutraScience's Debt-to-EBITDA too high?
Burcon NutraScience's current Debt-to-EBITDA is -2.20. Based on the distribution chart, Burcon NutraScience ranks #999999 out of 1554 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Burcon NutraScience has a GF Score™ of 32/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Burcon NutraScience's Debt-to-EBITDA compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Burcon NutraScience ranks #999999 out of 1554 companies for Debt-to-EBITDA. This places Burcon NutraScience in the lower half of its industry. The industry median Debt-to-EBITDA is 2.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Consumer Packaged Goods company?
The median Debt-to-EBITDA among Consumer Packaged Goods companies is 2.07, based on 1,554 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Burcon NutraScience. For the Consumer Packaged Goods industry, the median Debt-to-EBITDA is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Burcon NutraScience's current Debt-to-EBITDA is -2.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Burcon NutraScience stock overvalued right now?
Based on GuruFocus' analysis, Burcon NutraScience (BRCNF) is currently considered Possible Value Trap. The stock's GF Value™ is $7.65, compared to a current price of $1.34 — trading 82.5% below its estimated fair value. The current Debt-to-EBITDA is -2.20. Burcon NutraScience's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Burcon NutraScience (BRCNF), the current Debt-to-EBITDA is -2.20 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Burcon NutraScience (BRCNF) Overvalued in 2026?
Based on GuruFocus' analysis, Burcon NutraScience stock appears to be undervalued.
The current stock price of $1.34 is trading 82.5% below its estimated GF Value™ of $7.65.
GuruFocus considers Burcon NutraScience to be Possible Value Trap.
Key valuation signals for BRCNF:
Debt-to-EBITDA: -2.20
GF Value™: $7.65 vs. price of $1.34 (82.5% below fair value)
No single metric tells the full story. See the BRCNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Burcon NutraScience Corp is a technology company in the development of plant-based proteins. With several issued patent applications, that have been developed, Burcon has grown a portfolio of composition, application, and process patents covering novel plant-based proteins derived from pea, canola, soy, hemp, sunflower seed, and more. Its joint venture Merit Foods is building a protein production facility in Manitoba, Canada, where it will produce, under license, Burcon's novel pea and canola protein ingredients.
32GF Score
Get the complete analysis for BRCNF
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BRCNF has been successfully added to your 
